UA115585C2 - Фармацевтичний препарат, що містить фосфатидилхолін, для лікування виразкового коліту - Google Patents

Фармацевтичний препарат, що містить фосфатидилхолін, для лікування виразкового коліту

Info

Publication number
UA115585C2
UA115585C2 UAA201509138A UAA201509138A UA115585C2 UA 115585 C2 UA115585 C2 UA 115585C2 UA A201509138 A UAA201509138 A UA A201509138A UA A201509138 A UAA201509138 A UA A201509138A UA 115585 C2 UA115585 C2 UA 115585C2
Authority
UA
Ukraine
Prior art keywords
acid
phosphatidylcholine
pharmaceutical formulation
ulcerative colitis
treatment
Prior art date
Application number
UAA201509138A
Other languages
English (en)
Ukrainian (uk)
Inventor
Герхард Кайлхойєр
Original Assignee
Ліпід Терапевтікс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ліпід Терапевтікс Гмбх filed Critical Ліпід Терапевтікс Гмбх
Publication of UA115585C2 publication Critical patent/UA115585C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UAA201509138A 2013-03-26 2014-03-25 Фармацевтичний препарат, що містить фосфатидилхолін, для лікування виразкового коліту UA115585C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13161089 2013-03-26
PCT/EP2014/055947 WO2014154683A1 (en) 2013-03-26 2014-03-25 Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis

Publications (1)

Publication Number Publication Date
UA115585C2 true UA115585C2 (uk) 2017-11-27

Family

ID=47913311

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201509138A UA115585C2 (uk) 2013-03-26 2014-03-25 Фармацевтичний препарат, що містить фосфатидилхолін, для лікування виразкового коліту

Country Status (26)

Country Link
US (1) US20160045523A1 (ja)
EP (1) EP2978416B1 (ja)
JP (1) JP6262843B2 (ja)
KR (1) KR20150132841A (ja)
CN (1) CN105377247B (ja)
AU (1) AU2014243102B2 (ja)
BR (1) BR112015023849A2 (ja)
CA (1) CA2907401A1 (ja)
CL (1) CL2015002832A1 (ja)
DK (1) DK2978416T3 (ja)
EA (1) EA029514B1 (ja)
ES (1) ES2605650T3 (ja)
HK (1) HK1217089A1 (ja)
HU (1) HUE030707T2 (ja)
IL (1) IL241019A0 (ja)
LT (1) LT2978416T (ja)
MD (1) MD20150089A2 (ja)
MX (1) MX2015013511A (ja)
PE (1) PE20160037A1 (ja)
PH (1) PH12015502199A1 (ja)
PL (1) PL2978416T3 (ja)
PT (1) PT2978416T (ja)
SG (1) SG11201507777TA (ja)
UA (1) UA115585C2 (ja)
WO (1) WO2014154683A1 (ja)
ZA (1) ZA201507910B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1008752B1 (pt) 2009-02-16 2020-02-11 Nogra Pharma Limited Compostos alquilamido, composições farmacêuticas e usos dos mesmos
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
CA3014575A1 (en) * 2016-02-26 2017-08-31 Nogra Pharma Limited Methods of treating lactose intolerance
CN113825739A (zh) 2019-02-08 2021-12-21 诺格拉制药有限公司 制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法
WO2020177728A1 (zh) 2019-03-05 2020-09-10 四川国为制药有限公司 脂肪酸组合物及其应用
CN113368118B (zh) * 2021-07-21 2022-09-23 中国药科大学 磷脂酰胆碱在制备治疗溃疡性结肠炎的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022136C2 (de) * 1980-06-13 1986-07-17 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zum Abfüllen von Phospholipide enthaltenden pharmazeutischen Massen in Hartkapseln
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
IT1243981B (it) * 1990-10-01 1994-06-28 Fidia Spa Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina
US5453523A (en) * 1993-06-16 1995-09-26 Emulsion Technology, Inc. Process for obtaining highly purified phosphatidylcholine
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
ES2211184T3 (es) * 1998-08-06 2004-07-01 Wolfgang Stremmel Fosfatidilcolina como medicamento con efecto protector de mucosas.
SI2185158T1 (sl) * 2007-07-31 2014-08-29 Pat Gmbh Uporaba fosfatidilholina za zdravljenje steroidno odvisnega in steroidno refraktarnega ulcerativnega kolitisa
CN102633832B (zh) * 2011-02-09 2015-07-22 北京绿色金可生物技术股份有限公司 一种制备高纯度磷脂酰胆碱的方法

Also Published As

Publication number Publication date
EP2978416A1 (en) 2016-02-03
PL2978416T3 (pl) 2017-03-31
CA2907401A1 (en) 2014-10-02
CL2015002832A1 (es) 2016-03-11
HK1217089A1 (zh) 2016-12-23
IL241019A0 (en) 2015-11-30
DK2978416T3 (en) 2016-12-19
EP2978416B1 (en) 2016-10-26
AU2014243102B2 (en) 2018-04-26
HUE030707T2 (en) 2017-05-29
AU2014243102A1 (en) 2015-09-17
ES2605650T3 (es) 2017-03-15
PT2978416T (pt) 2016-12-09
CN105377247B (zh) 2019-04-26
KR20150132841A (ko) 2015-11-26
CN105377247A (zh) 2016-03-02
PE20160037A1 (es) 2016-02-04
WO2014154683A1 (en) 2014-10-02
MD20150089A2 (ro) 2016-03-31
US20160045523A1 (en) 2016-02-18
PH12015502199A1 (en) 2016-01-25
EA029514B1 (ru) 2018-04-30
SG11201507777TA (en) 2015-10-29
ZA201507910B (en) 2017-04-26
MX2015013511A (es) 2016-06-28
JP6262843B2 (ja) 2018-01-17
BR112015023849A2 (pt) 2017-07-18
LT2978416T (lt) 2016-12-12
JP2016516087A (ja) 2016-06-02
EA201591510A1 (ru) 2016-01-29

Similar Documents

Publication Publication Date Title
PH12015502199A1 (en) Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis
ZA201704820B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
MY188027A (en) Fat composition and fat blend
NZ709486A (en) Solid solution compositions and use in chronic inflammation
MY198214A (en) Fatty acid composition and use thereof
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
ZA201704821B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
SG11201501013PA (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
MX2014000770A (es) Composiciones de acidos grasos.
IN2015DN02929A (ja)
IN2014DN07483A (ja)
MX2015011767A (es) Composiciones de aceite crudo de algas.
CO2017001088A2 (es) Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
HK1223126A1 (zh) 不飽和脂肪酸酶和二十碳五烯酸的製備方法
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
MX2018010235A (es) Mezclas de bispiribac.
PH12015500793B1 (en) Control agent for plant pest and/or plant disease
MX2016006548A (es) Composicion estabilizada liquida de baja concentracion de metsulfuron-metilo.
SG11201509243VA (en) Integrated process for the production of acrylic acids and acrylates
MX2015009305A (es) Formulacion, preparacion y uso de un biocombustible basado en glicerol.
NZ708578A (en) Leptospira with increased antigenic mass
CO7240409A2 (es) Compuestos a partir de los frutos de acrocomia crispa y acromia aculeata contra la inflamación y el estres oxidativo
MY182731A (en) Fat composition
MY185373A (en) Sus-type triglyceride composition